The Safety and Long-Term Clinical Benefit of PCSK9i in STEMI Patients
NCT05579418
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
350
Enrollment
INDUSTRY
Sponsor class
Conditions
STEMI
Dyslipidemias
Interventions
DRUG:
Evolocumab
Sponsor
Hamad Medical Corporation